NPPA releases revised price list of 631 products under five medical devices
The National Pharmaceutical Pricing Authority (NPPA) has released price listing of 631 medical devices, which falls under the five medical devices it capped trade margins at 70 per cent at the Price to Distributor (PTD) level earlier this month
Engineering | 26/07/2021 | By Darshana | 390
US FDA approves fexinidazole as the first all-oral treatment for sleeping sickness
The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness (Human African trypanosomiasis) in patients 6 years of age and older and weighing at least 20 kg
Engineering | 20/07/2021 | By Darshana | 247
The National Pharmaceutical Pricing Authority (NPPA) has asked drug manufacturers and marketers to furnish the information relating to price to retailer (PTR) and moving annual turnover (MAT) in value term for about 29 NLEM formulations for the month of March 2021. The information will be used by NPPA for fixing ceiling price of the formulations
Engineering | 13/07/2021 | By Darshana | 384
Seegene announced on June 1 the signing of an agreement with Bio-Rad Laboratories, Inc. to develop and commercialize products for molecular diagnostics of infectious diseases. Under the terms of the agreement, Seegene will provide diagnostic tests for use in Bio-Rad's CFX96 Dx Real-Time PCR System for the United States market
Engineering | 08/07/2021 | By Darshana | 251
Labcorp introduces companion diagnostic for Amgen's new lung cancer therapy, Lumakras
Labcorp, a leading global life sciences company, announced the availability of therascreen KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with non-small cell lung cancer (NSCLC) who are eligible for treatment with Lumakras (sotorasib), a new treatment option developed by Amgen
Engineering | 05/07/2021 | By Darshana | 187
Royal Philips, a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique that could potentially revolutionize the use of MR imaging in cardiology
Engineering | 03/07/2021 | By Darshana | 235
ATAL Faculty Development Programme deliberate on novel ideas in drug design and engineering
The programme was jointly organized by Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR) and Delhi Pharmaceutical Sciences and Research University (DPSRU) in which lectures were delivered by prominent scientists from around the country in the field of pharmaceutical sciences
Engineering | 29/06/2021 | By Darshana | 334
Wipro GE Healthcare begins local manufacturing of Versana ultrasound range in India
Wipro GE Healthcare, one of the leading Ultrasound manufacturers in India, has enhanced its local capability to manufacture a wide range of Versana products in India. This is as part of the company's strategy to expand localization and strengthen the supplier ecosystem. The Versana Ultrsound range is part of the company's affordable product portfolio
Engineering | 23/06/2021 | By Darshana | 250
Cleveland Clinic research identifies link between gut microbes and stroke
New findings from researchers at Cleveland Clinic, a top American hospital, show for the first time that the gut microbiome impacts stroke severity and functional impairment following stroke. The results, published in Cell Host & Microbe, lay the groundwork for potential new interventions to help treat or prevent stroke
Engineering | 22/06/2021 | By Darshana | 284
The Janssen Pharmaceutical Companies of Johnson & Johnson announced primary results from the pivotal phase 3 GLOW study (NCT03462719) evaluating fixed-duration Imbruvica plus venetoclax (I+V) compared to chlorambucil plus obinutuzumab (Clb+O) for first-line treatment of elderly or unfit patients with chronic lymphocytic leukemia (CLL)
Engineering | 14/06/2021 | By Darshana | 281
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy